Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified Release Metaxalone in Acute Lumbosacral Musculoskeletal Conditions
NCT06157177Phase 4Recruiting
- Sponsor
- Primus Pharmaceuticals
- Start
- Nov 2023
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of metaxalone in Sciatica, lumbar spinal stenosis (LSS), low back pain (LBP), sponsored by Primus Pharmaceuticals. Started Nov 2023; status: recruiting.
02
Drugs
metaxalone
03
Conditions
Sciaticalumbar spinal stenosis (LSS)low back pain (LBP)
Beyond the preview
Go deeper on NCT06157177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06157177.